SEROCON R & D Biotechnology

SEROCON; it was established in 2017 with the aim of producing internal and external quality control materials, R&D infrastructure, academic experiences and field experiences, which were taken from abroad until recently, in accordance with European Union standards, protecting the national capital and contributing to the economy of the country.

SEROCON; after successfully completing the industrial product development procedure that requires multidisciplinary teamwork, it has put its internal and external quality control materials into domestic and international use. It continues its R&D studies without interruption in order to develop innovative products for the needs of the health sector.